These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34239267)

  • 21. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
    Goyal A; Murray JM
    Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing hepatitis delta in primary care practices in the US: a narrative review.
    Kushner T; Andrews RR
    Curr Med Res Opin; 2024 May; 40(5):813-820. PubMed ID: 38487951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Delta hepatitis: Epidemiology, diagnostic, natural history and treatment].
    Loureiro D; Castelnau C; Bed CM; Asselah T
    Rev Med Interne; 2022 Mar; 43(3):160-169. PubMed ID: 34799189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.
    Wang W; Lempp FA; Schlund F; Walter L; Decker CC; Zhang Z; Ni Y; Urban S
    J Hepatol; 2021 Aug; 75(2):311-323. PubMed ID: 33845061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
    Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen PJ; Cheon ME; Chuang WL; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg AS; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu YC; Hu CC; Huang JF; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao JH; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee MH; Lim YS; Marotta PJ; Navas MC; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang HI; Yu ML; Zuckerman E;
    J Hepatol; 2023 Aug; 79(2):576-580. PubMed ID: 37030400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology and clinical characteristics of hepatitis delta virus (HDV) infected patients with elevated transaminases in Shanghai, China.
    Wu S; Zhang Y; Tang Y; Yao T; Lv M; Tang Z; Zang G; Yu Y; Chen X
    BMC Infect Dis; 2020 Aug; 20(1):565. PubMed ID: 32746807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
    Colagrossi L; Salpini R; Scutari R; Carioti L; Battisti A; Piermatteo L; Bertoli A; Fabeni L; Minichini C; Trimoulet P; Fleury H; Nebuloso E; De Cristofaro M; Cappiello G; Spanò A; Malagnino V; Mari T; Barlattani A; Iapadre N; Lichtner M; Mastroianni C; Lenci I; Pasquazzi C; De Sanctis GM; Galeota Lanza A; Stanzione M; Stornaiuolo G; Marignani M; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Perno CF; Coppola N; Svicher V
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29987240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapies for hepatitis delta virus infection.
    Loureiro D; Castelnau C; Tout I; Boyer N; Narguet S; Menasria Benazzouz S; Louis Z; Pons-Kerjean N; Giuly N; Marcellin P; Mansouri A; Asselah T
    Liver Int; 2021 Jun; 41 Suppl 1():30-37. PubMed ID: 34155804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aiming for cure in HBV and HDV infection.
    Petersen J; Thompson AJ; Levrero M
    J Hepatol; 2016 Oct; 65(4):835-848. PubMed ID: 27270043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hepatitis delta and HIV infection.
    Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
    Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The adventure of delta.
    Rizzetto M
    Liver Int; 2016 Jan; 36 Suppl 1():135-40. PubMed ID: 26725911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis delta virus.
    Hughes SA; Wedemeyer H; Harrison PM
    Lancet; 2011 Jul; 378(9785):73-85. PubMed ID: 21511329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
    Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
    Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological and molecular features of hepatitis B and hepatitis delta virus transmission in a remote rural community in central Africa.
    François-Souquière S; Makuwa M; Bisvigou U; Kazanji M
    Infect Genet Evol; 2016 Apr; 39():12-21. PubMed ID: 26747245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
    Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
    Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of NTCP-inhibitor myrcludex B.
    Cheng D; Han B; Zhang W; Wu W
    J Viral Hepat; 2021 Jun; 28(6):852-858. PubMed ID: 33599010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus.
    Sausen DG; Shechter O; Bietsch W; Shi Z; Miller SM; Gallo ES; Dahari H; Borenstein R
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis D virus: Improving virological knowledge to develop new treatments.
    Khalfi P; Kennedy PT; Majzoub K; Asselah T
    Antiviral Res; 2023 Jan; 209():105461. PubMed ID: 36396025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.